Works by Avigdor, Abraham


Results: 69
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S395, doi. 10.1016/S2152-2650(21)01896-6
    By:
    • Olszewski, Adam;
    • Avigdor, Abraham;
    • Babu, Sunil;
    • Levi, Itai;
    • Eradat, Herbert;
    • Abadi, Uri;
    • Holmes, Houston;
    • McKinney, Matthew;
    • Woszczyk, Dariusz;
    • Giannopoulos, Krzysztof;
    • Jurczak, Wojciech;
    • McCord, Ron;
    • Yuying Xie;
    • Mingzhu Zhou;
    • Qayum, Naseer;
    • O'Hear, Carol;
    • Sellam, Gila;
    • Horowitz, Netanel
    Publication type:
    Article
    21

    Poster: ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S239, doi. 10.1016/S2152-2650(21)01501-9
    By:
    • Olszewski, Adam;
    • Avigdor, Abraham;
    • Babu, Sunil;
    • Levi, Itai;
    • Eradat, Herbert;
    • Abadi, Uri;
    • Holmes, Houston;
    • McKinney, Matthew;
    • Woszczyk, Dariusz;
    • Giannopoulos, Krzysztof;
    • Jurczak, Wojciech;
    • McCord, Ron;
    • Yuying Xie;
    • Mingzhu Zhou;
    • Qayum, Naseer;
    • O'Hear, Carol;
    • Sellam, Gila;
    • Horowitz, Netanel
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC.

    Published in:
    Expert Review of Anticancer Therapy, 2024, v. 24, n. 9, p. 893, doi. 10.1080/14737140.2024.2373888
    By:
    • Peterlin, Pierre;
    • Saada-Bouzid, Esma;
    • Moskovitz, Mor;
    • Pigneux, Arnaud;
    • Yuda, Junichiro;
    • Sinnollareddy, Mahipal;
    • Henner, William R.;
    • Chen, Diana;
    • Freise, Kevin J.;
    • Leibman, Rachel S.;
    • Avigdor, Abraham;
    • Shimizu, Toshio
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.

    Published in:
    Pharmaceutical Research, 2019, v. 36, n. 7, p. N.PAG, doi. 10.1007/s11095-019-2605-8
    By:
    • Lavezzi, Silvia Maria;
    • de Jong, Jan;
    • Neyens, Martine;
    • Cramer, Paula;
    • Demirkan, Fatih;
    • Fraser, Graeme;
    • Bartlett, Nancy;
    • Dilhuydy, Marie-Sarah;
    • Loscertales, Javier;
    • Avigdor, Abraham;
    • Rule, Simon;
    • Samoilova, Olga;
    • Goy, Andre;
    • Ganguly, Siddhartha;
    • Salman, Mariya;
    • Howes, Angela;
    • Mahler, Michelle;
    • De Nicolao, Giuseppe;
    • Poggesi, Italo
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50